The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
189 - Dear PAAB: We have a HCP-directed APS for a congress announcing "Company A name" and "Product B name" are "now here" in Canada. An offer to "visit at Conference Booth XXXX" is included. There are no further product / therapeutic claims. Is this exempt from PAAB preclearance review, as per the "now available" exemption in S6.6?; and If so, may we include product branding elements / visuals and maintain exemption? Thanks!
FYI post-approval change/preclearance exemption/what requires review/PAAB scope
1
Posts
1
Posters
327
Views
1
Watching
